Jayantha Ratnayake

Suggest Changes
Learn More
TPS118 Background: Pertuzumab (P) is a promising new anti-HER2 antibody which has shown both activity and good tolerability when combined with trastuzumab (H) in patients with HER2-positive breast(More)
  • 1